What you need to know about children's COVID-19: a systematic review.
10.7499/j.issn.1008-8830.2106122
- Author:
Majid Mohammed MAHMOOD
1
;
Ilhama JAFARLI
2
;
Aras Fathi AL-BARAZANCHI
3
;
Nadhim Mohammed MOSA
4
;
Zenab Ghanim Younus AL-AMEEN
5
;
Taghreed ALKHANCHI
6
Author Information
1. Unit of Zoonotic Diseases, College of Veterinary Medicine, University of Baghdad, Iraq, Baghdad, Iraq.
2. Pediatric Surgery Department, Cardiff and Vale University Hospital, Heath Park. CF14 4XW, Cardiff, Wales, UK.
3. Department of Pediatrics, Pediatric Hospital, Halabja, Halabja Road, Sulimanyha, Postal code 46018, Kurdistan Region of Iraq.
4. Department of Radiology Techniques, Al-Qalam University College, Nawroz City, Erbil, Postal code 44001, Iraq.
5. Division of Pharmaceuticals, Al-Adel Health Sector, Al-Kharkh Health Center, Ministry of Health, Baghdad, Postal code 10006, Iraq.
6. Batcher in Chemistry and Pharmaceutical Science, Baghdad, Iraq.
- Publication Type:Systematic Review
- Keywords:
Asymptomatic;
Child;
Coronavirus disease 2019;
Kawasaki disease
- MeSH:
Adult;
COVID-19;
Child;
Humans;
SARS-CoV-2
- From:
Chinese Journal of Contemporary Pediatrics
2021;23(11):1080-1090
- CountryChina
- Language:English
-
Abstract:
The aim of the systematic review is to describe clinical features of coronavirus disease 2019 (COVID-19) in children with a focus on the possible reasons why children are less susceptible to COVID-19 and whether their immune response works better than adults. The three research questions below were determined. (1) Why do pediatric COVID-19 cases have milder clinical symptoms than adults? (2) What are clinical manifestations, diagnosis, and treatment of COVID-19 in children? (3) How long lasts viral shedding after recovery? We searched MEDLINE, Embase, Cochrane Central Register of Controlled Trials, and Cochrane Database of Abstracts of Reviews of Effects, as well as foreign literature with English translations. Extra information and data have been collected from Google Scholar and the American Society for Microbiology. Information on patients' age, comorbidities, methods of treatment, and effects on mortality and morbidity were extracted. It is concluded that children are less susceptible to COVID-19 than adults and that the symptoms in children are less severe than in adults. A low incidence of COVID-19 in children and milder disease than in adults might be attributed to many theories and reasons; however, the mechanisms involved are not fully understood.
